Supreme Court's Upcoming Decisions Could Reshape Abortion Access

Two pivotal cases may determine the future of medication and emergency abortion care in the United States.

Overview

The Court is reviewing a challenge to FDA-approved mifepristone, a key medication for abortions.
A separate case involves whether emergency abortion care is mandated under federal law.
Legal standing of anti-abortion plaintiffs is a critical issue in both cases.
Decisions are expected by late June or early July, potentially impacting upcoming elections.
States like Missouri, Kansas, and Idaho may continue legal battles regardless of the rulings.